Considered the founder of the industry, Genentech, now a member of the Roche Group, has been delivering on the promise of biotechnology for more than 40 years.
Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. Our transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis.
Texas Covered is the largest event of its kind in Texas and brings together decision-makers from across the health care spectrum—from major health plans, providers and regulators, to legislators, journalists, academics and more.
